These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 15731778)
81. Dual inactivation of RB and p53 pathways in RAS-induced melanomas. Bardeesy N; Bastian BC; Hezel A; Pinkel D; DePinho RA; Chin L Mol Cell Biol; 2001 Mar; 21(6):2144-53. PubMed ID: 11238948 [TBL] [Abstract][Full Text] [Related]
82. Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas. Bai M; Vlachonikolis J; Agnantis NJ; Tsanou E; Dimou S; Nicolaides C; Stefanaki S; Pavlidis N; Kanavaros P Mod Pathol; 2001 Nov; 14(11):1105-13. PubMed ID: 11706071 [TBL] [Abstract][Full Text] [Related]
83. Effect of extracts from Radix Ginseng, Radix Notoginseng and Rhizoma Chuanxiong on delaying aging of vascular smooth muscle cells in aged rats. Tao LL; Lei Y; Wang GL; Zhu LQ; Wang Y Chin J Integr Med; 2012 Aug; 18(8):582-90. PubMed ID: 22855034 [TBL] [Abstract][Full Text] [Related]
84. G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder. Niehans GA; Kratzke RA; Froberg MK; Aeppli DM; Nguyen PL; Geradts J Br J Cancer; 1999 Jun; 80(8):1175-84. PubMed ID: 10376969 [TBL] [Abstract][Full Text] [Related]
85. Alterations of the p16/Rb/cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosus. Lerma E; Esteller M; Herman JG; Prat J Hum Pathol; 2002 Nov; 33(11):1120-5. PubMed ID: 12454817 [TBL] [Abstract][Full Text] [Related]
86. p16 and p53 can Serve as Prognostic Markers for Head and Neck Squamous Cell Carcinoma. Wang Y; Wang F; Wang S; Zhang L; Fu H; Sun L; Wang W; Liu C; Ren W; Gao L; Xing G; Ma X Int Dent J; 2024 Jun; 74(3):543-552. PubMed ID: 38105167 [TBL] [Abstract][Full Text] [Related]
87. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features. Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796 [TBL] [Abstract][Full Text] [Related]
88. The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1. Burnworth B; Arendt S; Muffler S; Steinkraus V; Bröcker EB; Birek C; Hartschuh W; Jauch A; Boukamp P Eur J Cell Biol; 2007 Dec; 86(11-12):763-80. PubMed ID: 17198740 [TBL] [Abstract][Full Text] [Related]
89. Abnormal expression of pRb, p16, and cyclin D1 in gastric adenocarcinoma and its lymph node metastases: relationship with pathological features and survival. Feakins RM; Nickols CD; Bidd H; Walton SJ Hum Pathol; 2003 Dec; 34(12):1276-82. PubMed ID: 14691913 [TBL] [Abstract][Full Text] [Related]
90. p53, Cyclin D1, p21 (WAF1) and Ki-67 (MIB1) Expression at Invasive Tumour Fronts of Oral Squamous Cell Carcinomas and Development of Local Recurrence. Sawair F; Hassona Y; Irwin C; Stephenson M; Hamilton P; Maxwell P; Gordon D; Leonard A; Napier S Asian Pac J Cancer Prev; 2016; 17(3):1243-9. PubMed ID: 27039754 [TBL] [Abstract][Full Text] [Related]
91. Prognostic value of cyclin D1 overexpression in correlation with pRb and p53 status in non-small cell lung cancer (NSCLC). Dworakowska D; Jassem E; Jassem J; Boltze C; Wiedorn KH; Dworakowski R; Skokowski J; Jaśkiewicz K; Czestochowska E J Cancer Res Clin Oncol; 2005 Jul; 131(7):479-85. PubMed ID: 15809880 [TBL] [Abstract][Full Text] [Related]
92. TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, CDK4, RB, MDM2, and EGFR in cancers of the uterine corpus. Skomedal H; Kristensen GB; Nesland JM; Børresen-Dale AL; Tropé C; Holm R J Pathol; 1999 Apr; 187(5):556-62. PubMed ID: 10398121 [TBL] [Abstract][Full Text] [Related]
93. The p16-cyclin D1/CDK4-pRb pathway and clinical outcome in epithelial ovarian cancer. Kusume T; Tsuda H; Kawabata M; Inoue T; Umesaki N; Suzuki T; Yamamoto K Clin Cancer Res; 1999 Dec; 5(12):4152-7. PubMed ID: 10632354 [TBL] [Abstract][Full Text] [Related]
94. P16 but not retinoblastoma expression is related to clinical outcome in no-special-type triple-negative breast carcinomas. Bogina GS; Lunardi G; Marcolini L; Brunelli M; Bortesi L; Marconi M; Coati F; Valerio M; Guerriero M; Massocco A; Pegoraro MC; Zamboni G Mod Pathol; 2014 Feb; 27(2):204-13. PubMed ID: 23887295 [TBL] [Abstract][Full Text] [Related]
95. Expression of the cell-cycle regulatory proteins (pRb, cyclin D1, p16INK4A and cdk4) in human endometrial cancer: correlation with clinicopathological features. Semczuk A; Miturski R; Skomra D; Jakowicki JA Arch Gynecol Obstet; 2004 Jan; 269(2):104-10. PubMed ID: 14648178 [TBL] [Abstract][Full Text] [Related]
96. Molecular and immunohistochemical analysis of the prognostic value of cell-cycle regulators in urothelial neoplasms of the bladder. Yurakh AO; Ramos D; Calabuig-Fariñas S; López-Guerrero JA; Rubio J; Solsona E; Romanenko AM; Vozianov AF; Pellin A; Llombart-Bosch A Eur Urol; 2006 Sep; 50(3):506-15; discussion 515. PubMed ID: 16624482 [TBL] [Abstract][Full Text] [Related]
97. Alterations in cyclin D1 expression in esophageal squamous cell carcinoma in the Indian population. Mathew R; Arora S; Khanna R; Shukla NK; Mathur M; Ralhan R J Cancer Res Clin Oncol; 2001 Apr; 127(4):251-7. PubMed ID: 11315260 [TBL] [Abstract][Full Text] [Related]
98. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias. Nasser W; Flechtenmacher C; Holzinger D; Hofele C; Bosch FX J Oral Pathol Med; 2011 Sep; 40(8):629-35. PubMed ID: 21435003 [TBL] [Abstract][Full Text] [Related]
99. Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma. Ishikawa T; Furihata M; Ohtsuki Y; Murakami H; Inoue A; Ogoshi S Br J Cancer; 1998; 77(1):92-7. PubMed ID: 9459151 [TBL] [Abstract][Full Text] [Related]